Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Synthetic Antibody Neutralizing Gluten in Development

Oliver Spadiut

An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten. . . . → Read More: Synthetic Antibody Neutralizing Gluten in Development

Spin-Off Company Developing New Antibiotics

MRSA bacteria

A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics

Small Business Grant Supports Bone Fracture Technology

Philip and Stewart Low

An award from National Institutes of Health is funding development of a new injected drug that promises to repair bone fractures without surgery. . . . → Read More: Small Business Grant Supports Bone Fracture Technology

Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses

Cocaine addiction

The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses. . . . → Read More: Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses

Trial Testing Universal Nasal Spray Flu Vaccine in Children

Train pssengers in masks

A clinical trial is underway evaluating a vaccine given as a nasal spray among children and teens that promises to protect against multiple flu types. . . . → Read More: Trial Testing Universal Nasal Spray Flu Vaccine in Children

Gilead Gains Genome-Editing Hepatitis B Therapy

Hepatitis-B virus

Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver. . . . → Read More: Gilead Gains Genome-Editing Hepatitis B Therapy

Clinical Trial Testing Anti-Resistant Malaria Therapy

Malaria clinic

A clinical trial is getting underway that tests the safety and dosage levels of a new drug to treat malaria and block resistance from developing to it. . . . → Read More: Clinical Trial Testing Anti-Resistant Malaria Therapy

A.I. to Identify Treatment Drivers for Colorectal Cancer

Data and person graphic

A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer

Clinical Trial Underway for Lassa Fever Treatment

Lassa fever investigation

An early-stage clinical trial is underway to test a treatment for Lassa fever, a viral disease found in West Africa, infecting as many as 300,000 individuals a year. . . . → Read More: Clinical Trial Underway for Lassa Fever Treatment

Genetic Engineering with Algae Boosts Crop Photosynthesis

Researchers with tobacco plants

Researchers developed a genetic engineering technique adding algae genes to some staple crops for capturing more carbon dioxide during photosynthesis and improving their yields. . . . → Read More: Genetic Engineering with Algae Boosts Crop Photosynthesis